AI
EW icon

Atom Investors’s Edwards Lifesciences EW Stock Holding History

Atom Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,255
Closed -$248K – 605
2023
Q4 		$248K Sell
3,255
-3,629
-53% -$253K 0.04% 376
2023
Q3 		$477K Buy
+6,884
New +$553K 0.11% 239
2021
Q1 		– Sell
-14,604
Closed -$1.33M – 303
2020
Q4 		$1.33M Sell
14,604
-867
-6% -$71.9K 0.13% 171
2020
Q3 		$1.24M Buy
15,471
+11,102
+254% +$866K 0.12% 167
2020
Q2 		$302K Sell
4,369
-4,070
-48% -$289K 0.02% 318
2020
Q1 		$531K Sell
8,439
-1,650
-16% -$119K 0.05% 203
2019
Q4 		$785K Buy
10,089
+72
+0.7% +$5.62K 0.06% 166
2019
Q3 		$734K Sell
10,017
-3,099
-24% -$218K 0.05% 200
2019
Q2 		$808K Sell
13,116
-20,682
-61% -$1.25M 0.05% 274
2019
Q1 		$2.16M Sell
33,798
-6,189
-15% -$353K 0.18% 129
2018
Q4 		$2.04M Buy
+39,987
New +$2.02M 0.2% 92

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Atom Investors's EW Position: Q1 2024 in Review

Atom Investors sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 3,255 shares — an estimated $248K sold.

Atom Investors first reported a position in EW in Q4 2018 and held it in 11 quarters. The position peaked at $2.16M in Q1 2019. 1,281 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Atom Investors reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • Atom Investors sold 3,255 Edwards Lifesciences shares in Q1 2024, an estimated $248K.
  • Atom Investors first reported a position in Edwards Lifesciences in Q4 2018 and held it in 11 quarters.
  • Atom Investors's Edwards Lifesciences position peaked at $2.16M in Q1 2019.
  • 1,281 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Atom Investors's 13F filing for Q1 2024, filed 15 May 2024.